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Abstract
Kashin-Beck disease, a syndrome characterized by short stature, skeletal deformities, and arthropathy of multiple joints, is
highly prevalent in specific regions of Asia. The disease has been postulated to result from a combination of different
environmental factors, including contamination of barley by mold mycotoxins, iodine deficiency, presence of humic
substances in drinking water, and, importantly, deficiency of selenium. This multifunctional trace element, in the form of
selenocysteine, is essential for normal selenoprotein function, including attenuation of excessive oxidative stress, and for
the control of redox-sensitive molecules involved in cell growth and differentiation. To investigate the effects of skeletal
selenoprotein deficiency, a Cre recombinase transgenic mouse line was used to trigger Trsp gene deletions in osteo-
chondroprogenitors. Trsp encodes selenocysteine tRNA
[Ser]Sec, required for the incorporation of selenocysteine residues into
selenoproteins. The mutant mice exhibited growth retardation, epiphyseal growth plate abnormalities, and delayed skeletal
ossification, as well as marked chondronecrosis of articular, auricular, and tracheal cartilages. Phenotypically, the mice thus
replicated a number of the pathological features of Kashin-Beck disease, supporting the notion that selenium deficiency is
important to the development of this syndrome.
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Introduction
Kashin-Beck disease, an environmentally-induced musculoskel-
etal syndrome, is prevalent in millions of individuals residing within
specific regions of Tibet, China, Siberia, and North Korea [1–3].
The disease first becomes evident in childhood with affected
individuals exhibiting short stature, joint and limb deformities, and
radiographic evidence of delayed skeletal ossification [4,5]; features
attributed to impaired epiphyseal growth and chondronecrosis
[1,3,4,6].With age, severesecondary osteoarthritisof multiple joints
becomes evident. Although several factors have been implicated in
the pathogenesis of this disease, deficiency of dietary selenium
intake, and hence, profoundly low serum selenium levels represent
one of the most salient features of Kashin-Beck disease [1,7,8]. This
raised the possibility that deficiencies in one or more selenoproteins
might play key etiological roles in this musculoskeletal disorder.
Selenium is an essential dietary micronutrient that is associated
with various organic molecules, including the 21
st amino acid,
selenocysteine (Sec), that is required for the function of a class of
proteins known as the selenoproteins [9]. There are 25 human and
24 murine genes that encode for selenoproteins, approximately
one third of which function as antioxidants, protecting cells against
macromolecule damage caused by oxidative and/or nitrosative
stress [10]. Other members of the selenoprotein family include the
deiodinases, including, for example, deiodinase 2 (D2) that
catalyzes conversion of thyroxine (T4) into the active tri-
iodothyronine (T3) form; the latter has many roles in growth
and development, including the regulation of epiphyseal growth
plate differentiation [11–13]. Selenoprotein synthesis requires that
Sec residues be inserted into the growing polypeptide chains via
specific UGA codons present within the coding regions of
selenoprotein mRNAs. Although UGA specifies a ‘stop’ codon
in the universal genetic code, it can also code for Sec with the
participation of a group of proteins that recognize the Sec insertion
sequence (SECIS) element located in the 39 untranslated region of
selenoprotein mRNAs [14]. UGA is recognized by Sec tRNA
(designated Sec tRNA
[Ser]Sec) which is encoded by Trsp (present in
one copy per haploid genome).
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[Ser]Sec is responsible for the expression of all
selenoproteins and thus it provides a unique tool for studying
the role of selenium within this class of proteins. The targeted
deletion of Trsp is embryonic lethal owing to a loss of activity of
selenoproteins that are essential for normal growth and develop-
ment [15]. Hence, investigation of the tissue-specific consequences
of selenoprotein loss in vivo must be carried out via a conditional
mutagenesis approach. Cre-loxP technology has been successfully
used to study the consequences of floxed Trsp gene (Trsp
fl/fl)
excision in cardiac muscle, hepatocytes, lymphocytes, mammary
epithelium, and neurons, with pathological changes attributable to
selenoprotein deficiency being demonstrated in all these tissues [9].
In addition to dietary deficiency of selenium, deficiency of
iodine, ingestion of fungal mycotoxins from contaminated stored
food, high humic acid levels in the drinking water, or some
combination of these components have been proposed to have
roles in the genesis of Kashin-Beck disease [1,7,8,16]. The relative
contributions of the various environmental factors implicated in
Kashin-Beck disease are not known but an emphasis has been
placed on the role of selenium deficiency [1,17,18]. Induction of
dietary selenium and/or iodine deficiency in rodents, however,
fails to replicate many of the clinical features of Kashin-Beck
disease, while showing only modest effects on skeletal growth and
bone volume [17,18]. This could be due to the difficulty in
attaining the levels of selenium deficiency observed in Tibetan
children which are below 27 ng/ml in 90% of affected individuals.
Values in the 5 ng/ml range are observed in a third of affected
individuals [1]. In contrast, rats maintained on selenium deficient
diets only exhibited serum levels in the 30 ng/ml range [17].
We hypothesized that interfering with cartilage selenoprotein
synthesis, and hence mimicking the effects of severe selenium
deprivation in this tissue, might recapitulate features of Kashin-
Beck disease, including delayed endochondral bone development,
impaired ossification, chondronecrosis, and dwarfism. To test this
hypothesis, we deleted the Trsp gene in cells that give rise to the
skeleton. This was accomplished by generating Trsp
fl/fl mice
expressing the Cre recombinase under the control of the Col2a1
gene promoter in order to obtain Trsp deletions in osteo-
chondroprogenitors [19,20].
Results/Discussion
Targeted deletion of Trsp in skeletal precursor cells leads
to impaired skeletal growth and development and
premature death
Previous studies have shown that the generalized knockout of
Trsp is lethal at the embryonic stage [15,21]. To produce viable
individuals, we crossed a mouse with floxed Trsp alleles with a
transgenic line expressing the Cre recombinase under the control
of the Col2a1 promoter. Col2a1-Cre mice exhibited Cre-mediated
gene excision activity starting at approximately 9 days post coitum
(dpc) in notochord and cranial mesenchyme (sites where the
endogenous Col2a1 gene begins to be expressed), with Cre
reporter activity being evident in all cartilage primordia (ribs, long
bones, spine, basicranium) by 15 dpc [19]. Furthermore, using the
same b-galactosidase-based Cre reporter strain as Ovchinnikov et
al. [19], we detected Cre activity not only in mature cartilage and
endochondrally derived bone, but also within regions of the
cranium resulting from intra-membranous ossification [20]. These
results suggested that osteo-chondroprogenitors were the targets
for Cre-mediated genomic alterations in Col2a1-Cre transgenic
mice.
Compared to littermate controls, Col2a1-Cre; Trsp
fl/fl mice
demonstrated marked reduction in skeletal and cartilage growth.
As early as 1 wk after birth, the mutant mice began to exhibit
dwarfism, marked auricular hypoplasia, shortened snouts, de-
creased head size with frontal bossing, smaller limbs and shorter
tails (Figure 1A and 1B). Males and females were equally affected.
Interestingly, Col2a1-Cre; Trsp
fl/fl mice were indistinguishable from
control mice within the first few days after birth. Indeed, mouse
lengths (nose to tail base) measured on post-natal day 1, showed no
difference between the two groups (Figure 1C). In contrast, by 3.5–
4 weeks of age, the differences in length of the two groups had
become significant (Figure 1C), indicating that an additional factor
was involved, such as exposure to ambient oxygen. The 3.5–4 wk
time point was selected for analyses owing to the high incidence of
death (or need for euthanasia) in 4–5 wk old Col2a1-Cre; Trsp
fl/fl
mice (Figure 1D). Moribund animals demonstrated marked rib
cage indrawing, suggestive of inspiratory respiratory distress.
Impaired ossification, shortening of the long bones, and
widening of tibial growth plates in Col2a1-Cre; Trsp
fl/fl
mice
Radiographs of littermate control and Col2a1-Cre; Trsp
fl/fl mice
(Figure 2A) demonstrated the smaller skeletons of the mutant mice,
and the rounding of the cranium. The spaces between the
vertebral bodies, due to the intervertebral discs, were narrowed in
the mutant mice as compared with the littermate controls
(Figure 2A). The lumbar vertebrae of the Col2a1-Cre; Trsp
fl/fl mice
were smaller, with irregular outlines and were unevenly ossified.
These findings were confirmed by microcomputed tomography
(micro-CT) imaging of the lumbar vertebrae (Figure 2B). Micro-
CT also demonstrated the reduced cranial size and abnormal
cranial shape in Col2a1-Cre; Trsp
fl/fl mice (Figure 2C and 2D), with
snout shortening, narrowing of the jaw, and rounding of the
calvaria. This pattern is consistent with reduction in the growth of
the chondrocranial component of the skull. Indeed, other
mutations that perturb chondrocranial growth exhibit similar,
Author Summary
Kashin-Beck disease (KBD) is a severe, chronic, and
deforming musculoskeletal disease affecting millions of
individuals in specific regions of Asia. Starting in child-
hood, the disorder leads to joint and limb deformities,
short stature, and delayed skeletal development. Articular
cartilage damage due to chondronecrosis and limb
deformities then lead to secondary osteoarthritis and
severe disability. Factors proposed to cause KBD include
selenium deficiency, iodine deficiency, contamination of
grain with toxic molds, and humic substances in well
water. Soil and water deficiency in selenium (and iodine)
are a consistent feature of KBD endemic areas, and
affected individuals show profound deficiencies of these
two elements. Thus far, there have been no convincing
rodent models of KBD based on selenium (and/or iodine)
deficiency achieved through dietary manipulation. Our
manuscript describes a conditional gene mutation ap-
proach in mice that, in effect, mimics severe selenium
deficiency, achieving this specifically within skeletal
progenitor cells. By deleting selenocysteine tRNA (required
for normal selenoprotein activity) in osteo-chondropro-
genitors, we found that mice develop post-natal impair-
ment of skeletal growth, dwarfism, delayed ossification,
impaired endochondral bone formation, as well as severe
chondronecrosis. Our mutant mouse supports the idea
that selenium deficiency is key to the skeletal pathology of
KBD.
A Model for Kashin-Beck Disease
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fl/fl Col2a1-Cre mice exhibit runting and a shortened life-span. Frontal (A) and lateral (B) views of representative 4 wk old
Trsp
fl/fl Col2a1-Cre and control mice. Compared to the littermate control, the Trsp
fl/fl Col2a1-Cre animal is runted, with hypomorphic ears and a
shortened snout. (C) Lengths (from nose tip to base of tail) of groups of mice taken either at 1 day of age (n=7 Trsp
fl/fl Col2a1-Cre,n=4Trsp
fl/fl), or at
between 3.5–4 weeks of age (n=9 Trsp
fl/fl Col2a1-Cre,n=8Trsp
fl/fl). While lengths of control and experimental mice were similar in the immediate
post-natal period, by 3.5–4 weeks their lengths had diverged significantly. Data are mean+/2SEM. (D) Survival rates of mice followed for up to 7




Figure 2. Compromised skeletal development in Trsp
fl/fl Col2a1-Cre mice. (A) Radiographs of representative Trsp
fl/fl (left) and Trsp
fl/fl Col2a1-Cre
(right) mice. Arrows within the magnified areas highlight the irregularly-shaped vertebral bodies and narrowed intervertebral disc spaces in the Trsp
fl/fl
Col2a1-Cre spinal column. (B) Ventral and lateral micro-CT views of lumbar vertebrae from Trsp
fl/fl control (left) and Trsp
fl/fl Col2a1-Cre (right) mice showing
delayed spinal column ossification and loss of intervertebral disc spaces. (C) Micro-CT scans of the dorsal aspect of control (left) and experimental( r i g h t )
skulls showsmalleroverall headsize,rounding ofthe cranium(withpossibledecreasedfrontalboneossification),and nasal boneshorteninginthe Trsp
fl/fl
Col2a1-Cre mouse. (D) Generalized shape images of representative skulls. Ten mutant mice were used to generate this phenotypic average for the Trsp
fl/fl
Col2a1-Cre mice (red skull) and nine Trsp
fl/fl controls were used (grey skull); the overlay of the images is presented beneath. Note that skull sizes from the
control and experimental groups have been normalized, thus, only differences in shape of the cranium are being revealed by the overlay technique. (E)
Anterior micro-CT views of knee joints from control (left) and experimental (right) mice showing smaller overall size in the latter, yet with relatively wide
growth plates being present in the Trsp
fl/fl Col2a1-Cre tibia and fibula. (F) Cortical bone thickness difference (p=0.0005) between the genotypes at the
mid-shaft of the femur measured by micro-CT (n=5). Data are mean+/2SEM, and were from 3.5–4 wk old mice.
doi:10.1371/journal.pgen.1000616.g002
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The more porous nature of the frontal bones in the mutant,
evident in the micro-CT image of the cranium (Figure 2C), may
have been reflective of impaired intramembranous bone develop-
ment secondary to Col2a1-Cre mediated deletions of Trsp in
osteoblasts [20].
Micro-CT confirmed that smaller knees were a feature of the
mutant mice (Figure 2E). Quantitative micro-CT of femoral
cortical bone demonstrated that the Col2a1-Cre; Trsp
fl/fl long bones
were impaired in their mineralization (p=0.005) when compared
to the bones of littermate controls (Figure 2F). Interestingly,
despite the reduced size of the knees, the width of the radiolucent
gap corresponding to the tibial epiphyseal growth plates in was not
correspondingly reduced in the mutant mice. Histological sections
of mutant mice tibiae revealed increased epiphyseal growth plate
width despite reduced bone length. The epiphyses were also
characterized by a disorganized primary spongiosa in comparison
to littermate controls (Figure 3A and 3B). Indeed, there was an
approximate 45% increase in tibial growth plate width in the
mutant mice (data not shown) that was due to increases in both the
proliferative and hypertrophic chondrocyte zones (Figure 3C and
3D). This increased width was present despite the finding of
decreased cell proliferation (as shown by 5-bromo-2-deoxyuridine,
BrdU, incorporation) and only modest increases in TUNEL
(terminal deoxynucleotidyl transferase dUTP nick end-labeling)
positive apoptotic cells in the mutant growth plates (Figure 3E–
3G). We speculate that accumulation of cells in the proliferative
zone may have been the result of a slowing of the hypertrophic
differentiation process, and that hypertrophic zone expansion may
have been due to impaired osteoblastic invasion of this layer.
Abnormalities of cartilage in Col2a1-Cre; Trsp
fl/fl mice
Areas of chondronecrosis, a key pathological feature of Kashin-
Beck disease [3,4,6] were observed in cartilaginous tissues,
including the articular cartilage, ears, and tracheal rings. The
articular cartilage of a littermate control knee shown in Figure 4A
exemplifies the way that cartilage tissue sections should appear
when stained with hematoxylin, fast green and safranin O, with
the red stain indicating the presence of the glycosaminoglycans. In
contrast, areas of chondronecrosis were observed in the articular
cartilage of Col2a1-Cre; Trsp
fl/fl knees (Figure 4B and 4C), as
indicated through the loss of chondrocytes and glycosaminoglycan
staining. These areas of chondronecrosis were flanked by sparse
TUNEL positive apoptotic cells (Figure 4D). Chondronecrosis was
confined primarily to the femoral condylar and tibial plateau
articular cartilage, but were not evident within the tibial
epiphyseal growth plates. Massive chondronecrosis was evident
in the hypoplastic ears of the mutant mice (Figure 5A and 5B),
again these areas contained small numbers of TUNEL positive
chondrocytes (Figure 5C and 5D). Neutrophil infiltrates, a feature
of necrotic cell death, surrounded some of the chondronecrotic
areas in the ears (data not shown), and these necrotic regions were
often flanked by clusters of proliferating cells (Figure 5E and 5F),
possibly reflective of cartilage regeneration. Lastly, premature
death in Col2a1-Cre; Trsp
fl/fl mice appeared to result from
respiratory distress, and could be explained by tracheal narrowing
and/or collapse upon inspiration due to loss of tracheal ring
integrity due to the tracheomalacia. In keeping with this idea, we
found marked hypoplasia and chondronecrosis (Figure 6A and
6B), along with scattered TUNEL positive apoptotic cells
(Figure 6C and 6D), in Col2a1-Cre; Trsp
fl/fl tracheal cartilages.
To the best of our knowledge, there are no reports of an increase
frequency of tracheomalacia in newborns within Kashin-Beck
disease endemic areas.
To assess whether the targeted removal of Trsp in chondrocytes
resulted in a down-regulation of selenoprotein expression, immunoblot
analysis of chondrocytes for one of the major housekeeping
selenoproteins, thioredoxin reductase (TR1), was performed
(Figure 7A and 7B). This revealed a decrease in TR1 levels in the
chondrocytes of knockout mice as compared to control mice. In
contrast, TR1 levels were virtually unchanged in liver lysates, which
served as the control tissue. The reason a complete loss in TR1
expression was not observed in the chondrocyte preparation may have
been due to contaminating cell types such as fibroblasts in the lysate
preparations [24], and/or to incomplete excision of floxed Trsp by Cre
recombinase in chondrocytes [15]. Genomic PCR revealed that Trsp
excisions were present in the cartilage-rich tissues (xiphoid process, tail
tip) of Trsp
fl/fl Col2a1-Cre mice; however, the appearance of the un-
excised band in these tissues was again likely due to the presence of
non-chondrocytic cells in the tissue samples (Figure 7C). There was a
faint excision band present in the liver DNA samples, suggesting that
there was some low level of ‘leakiness’ of the Cre transgene in this
Figure3.Tibial epiphyseal growthplateabnormalitiesin Trsp
fl/fl
Col2a1-Cre mice. Relative sizes and morphological differences
between the tibiae of (A) Trsp
fl/fl (control), and (B) Trsp
fl/fl Col2a1-Cre
mice (hematoxylin and eosin stained sections) are shown. Note smaller
bone size, and the disproportionate widening of the epiphyseal growth
plate in the Trsp
fl/fl Col2a1-Cre mice. Higher magnification views of
representative growth plate sections from Trsp
fl/fl (C) and Trsp
fl/fl Col2a1-
Cre (D) mice; there was widening of both the proliferative (white two-
headedarrows)andhypertrophic(black two-headedarrows)zones inthe
mutant mice. BrdU+ nuclear staining revealed an increase in the number
of mitoses within the tibial growth plate proliferative zones of Trsp
fl/fl (E)
as compared to Trsp
fl/fl Col2a1-Cre (F) mice (arrows indicate examples of
BrdU+ cells). Scale bars were as follows: 450 mm (A and B), 55 mm (C and
D) and 27 mm (E and F). (G) Numbers of BrdU+ nuclei (n=14 Trsp
fl/fl
Col2a1-Cre and n=7 Trsp
fl/fl tibiae), and TUNEL positive apoptotic cells
(n=3 Trsp
fl/fl Col2a1-Cre andn=5 Trsp
fl/fl tibiae) present in the epiphyseal
growth plates. Data are shown as mean+/2SEM.
doi:10.1371/journal.pgen.1000616.g003
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tissues of the mutant mice, and this was accompanied by a decrease in
the expression level of an important selenoprotein, TR1.
The chondronecrosis and impaired skeletogenesis seen in Col2a1-
Cre; Trsp
fl/fl mice potentially results from chondrocyte and osteoblast
deficiencies in a range of different anti-oxidant selenoproteins,
including specific glutathione peroxidases (such as glutathione
peroxidases 1 and 4) and, as we have seen, thioredoxin reductases
(such as TR1) [9]. The antioxidant selenoproteins constitute an
important line of defense against cellular damage, necrosis, and
apoptosis brought about by excessive levels of reactive oxygen and
nitrogen species [25]. The thioredoxin reductases, for example, are
required for normal thioredoxin function, and as such support cell
proliferation and the activities of specific redox-sensitive molecules,
suchasspecifictranscriptionfactorsortheirregulators[26–28].The
idea that the post-natal onset of runting in Col2a1-Cre; Trsp
fl/fl mice
may have been due to exposure to ambient oxygen, and the ensuing
increase in oxidative stress, would be consistent with anti-oxidant
defenses ofchondrocytesand osteoblastshaving been compromised.
It was also possible that intracellular T3 deficiency, resulting from
decreased selenoprotein deiodinase activity, may have contributed to
the phenotype of Col2a1-Cre; Trsp
fl/fl mice. The thyroid secretes T4
into the circulationwhich must thenbe converted within target tissues
into the active T3 form by intracellular D2 [29,30]. T3,ah o r m o n e
utilized by all tissues, is also required for normal growth plate
development [11], and nuclear receptors for this ligand have been
shown to be expressed in skeletal cells [31]. Although diminished D2
deiodinase activity could theoretically lead to a tissue-specific
deficiency of T3, genetic deletion of D2, either alone or in
combination with D1, yielded no evidence of impaired skeletal
growth [32]. This is in keeping with recent data indicating that
neither D1 or D2 are expressed in rodent chondrocytes, and that D2
is only found in mature osteoblasts [33]. In contrast, D3, a deiodinase
that down-regulates intracellular T3 levels in the skeleton (to avoid
accelerated bone maturation), is expressed in young rodent
chondrocytes and osteoblasts. Thus, mice lacking D3 exhibited
generalized growth retardation attributed to perinatal thyrotoxicosis
and that was subsequently compounded by severe hypothyroidism
starting around the time of weaning [34]. In view of these results, we
hypothesize that osteo-chondroprogenitor specific deficiency of the
D3 selenoprotein in Col2a1-Cre; Trsp
fl/fl mice may have allowed the
accumulation of abnormally high concentrations of intracellular T3
during the perinatal period. Raised T3 levels would not only act to
accelerate bone maturation, but would also contribute to oxidative
stress [35], thus aggravating macromolecule damage in cells already
impaired in their selenoprotein-based anti-oxidant defenses.
Figure 4. Chondronecrosis in the articular cartilage of Trsp
fl/fl
Col2a1-Cre mice. (A) Triple-stained section of the femoral articular
cartilage of a Trsp
fl/fl control mouse; the red staining reveals the
presence of glycosaminoglycans in the extracellular matrix surrounding
the embedded chondrocytes. (B) Triple-stain of femoral articular
cartilage from a representative Trsp
fl/fl Col2a1-Cre mouse, showing
marked glycosaminoglycan depletion (pale red regions) in the areas of
chondronecrosis (arrowheads). (C) Hematoxylin and eosin-stained
section of distal femoral articular cartilage from another Trsp
fl/fl
Col2a1-Cre mouse, showing a typical region of chondronecrosis
(arrowheads). (D) TUNEL positive apoptotic cells (stained brown) lining
an area of chondronecrosis (arrowheads) in the distal femoral articular
cartilage of a Trsp
fl/fl Col2a1-Cre mouse knee. Scale bar=110 mm.
doi:10.1371/journal.pgen.1000616.g004
Figure 5. Auricular chondronecrosis and hypoplasia in Trsp
fl/fl
Col2a1-Cre mice. (A) Hematoxylin and eosin staining of ear cartilage
from a control Trsp
fl/fl mouse, compared with (B) Trsp
fl/fl Col2a1-Cre
auricular cartilage that shows a wide band of necrotic chondrocytes.
Detection of TUNEL positive cells (stained brown, with methyl-green
counterstain) in Trsp
fl/fl control (C) and Trsp
fl/fl Col2a1-Cre (D) auricular
cartilage. Note abundance of necrotic cells with scattered TUNEL
positive cells in (D). Evidence of apparent regenerative activity of
cartilage above and below the band of necrotic cartilage, but not in the
control (E), is shown (F). Detection of cell proliferation using anti-PCNA
antibody immunostaining on control Trsp
fl/fl (E) and Trsp
fl/fl Col2a1-Cre
(F) cartilage; haematoxylin counter stain. Scale bars are as follows:
55 mm (A,B,E,F), 27 mm (C,D).
doi:10.1371/journal.pgen.1000616.g005
A Model for Kashin-Beck Disease
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deficiency in humans has been associated with multiple skeletal
effects, including short stature, vertebral and cranial abnormalities,
as well as delayed endochondral bone formation and skeletal
maturation [36]. These phenotypic features, which may also be
due in part to neuro-endocrine axis abnormalities, are manifested
primarily as delays in growth and development, and can be
reversed by thyroid hormone administration. We are not aware of
any evidence showing that human hypothyroidism is associated
with chondronecrosis, and given the unremarkable phenotype of
D1 and D2 deficient mice [32], it is unlikely that T3 deficiency
within osteo-chondroprogenitor cells would, by itself, be able to
account for the skeletal phenotype of Col2a1-Cre; Trsp
fl/fl mice.
Lastly, given that very low serum levels of selenium and iodine
almost invariably coexist in individuals within Kashin-Beck disease
endemic regions [1], it raises the possibility that our dietary iodine-
proficient Col2a1-Cre; Trsp
fl/fl mice may not entirely mimic the
human syndrome. Indeed, it is conceivable that low iodine levels,
and hence reduced thyroid hormone activity, might actually be
protective in the presence of profound selenium deficiency.
The topic of iodine and selenium supplementation in individuals
residing in Kashin-Beck disease endemic areas and in those
exhibiting the clinical manifestations of this disorder has been
reviewed by Vanderpas [37]. In general, epidemiological studies
have suggested that either selenium or iodine supplementation
decrease the incidence and/or clinical severity of Kashin-Beck
disease. However, selenium supplementation in established disease
appeared not to have a beneficial clinical effect [38]. Regarding this
latter finding, it could be argued that once clinical manifestations are
present, some degree of permanent damage to joint and epiphyseal
cartilage has already occurred. Clearly, selenium and iodine
supplementation in Kashin-Beck endemic areas should be instituted
during gestation and then continued until skeletal maturity has been
reached soastopreventgrowthplateandarticularcartilagedamage,
and sequelae such as secondary osteoarthritis.
We have shown that the Trsp gene, and hence, preservation of
selenoprotein activity in osteo-chondroprogenitors, is essential to
murine skeletogenesis and the maintenance of cartilage viability.
Indeed, loss of Trsp was associated not only with defects in
cartilage and bone development, but also severe chondronecrosis
of auricular and tracheal cartilages. Our findings lend support to
the idea of selenium deficiency being a key factor in the
pathogenesis of the skeletal abnormalities of Kashin-Beck disease.
Materials and Methods
Generation of mice
Mice with floxed Trsp alleles [15], after being backcrossed (N=6)
onto the C57BL/6J genetic background, were then interbred with
mice expressing Cre recombinase under the control of a type II
collagen (Col2a1)g e n ep r o m o t e r[ 1 9 ] .T h el a t t e rw e r eo r i g i n a l l yo fa
Figure 6. Tracheomalacia and airway lumen narrowing in
Trsp
fl/fl Col2a1-Cre mice. (A) Triple-stained section of a trachea from
a representative Trsp
fl/fl (control) mouse, showing normal cartilage ring
cross-sections with abundant cells and glycosaminoglycan deposition
in the extracellular matrix (indicated by red staining); the connective
tissue is stained green. (B) Tracheal rings from a representative Trsp
fl/fl
Col2a1-Cre mouse were reduced in size, and showed a dramatic loss of
red staining as well as chondrocyte depletion; dystrophic calcification
was also present in some cartilage rings, for example, the dark staining
region in uppermost ring on the right side of the trachea in (B). The
lumen of the Trsp
fl/fl Col2a1-Cre tracheas was also narrowed. TUNEL
positive cells were not evident in the control tracheal cartilages (C),
however, scattered TUNEL positive chondrocytes were present within
areas of chondronecrosis within Trsp
fl/fl Col2a1-Cre tracheal rings (D).
Methyl-green counterstaining, used to indicate positions of cell nuclei,
also revealed loss of extracellular matrix staining in the Trsp
fl/fl Col2a1-
Cre rings (D) consistent with chondrocyte dysfunction or death. Scale
bars are 450 mm (A and B), and 27 mm (C and D).
doi:10.1371/journal.pgen.1000616.g006
Figure 7. Immunoblotting analysis of TR1 in chondrocytes and
demonstration of Trsp excisions in cartilage-rich tissues. Protein
extracts were prepared from (A) chondrocytes and (B) liver samples
from two control (Trsp
fl/fl) and three Trsp
fl/fl Col2a1-Cre) mice. Lysates
were then subjected to electrophoresis, transblotted, and probed with
an anti-TR1 antibody (upper panels) as described in the Materials and
Methods section. The lower panels show the Ponceau S-stained
membranes of the total protein extracts as loading controls.
Representative blots are shown. (C) Representative genotyping results
from tail tip, xiphisternal and liver DNA samples from control and
experimental mice. PCR reactions to detect Trsp
fl/fl 450 bp excision
band are shown in the upper panel; and PCR demonstrating the
presence of the Col2a1-Cre transgene are in the lower panel.
doi:10.1371/journal.pgen.1000616.g007
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(Bar Harbor, ME) but were subsequently fully (N.10) backcrossed
onto the C57BL/6J genetic background prior to their use in the
experiments reported herein. Tail tip clippings from pups were taken
immediately post-weaning and processed for genotyping for both the
Trsp
fl/fl and the Cre transgene. Cartilage-specific excision of Trsp was
verified using a previously PCR reaction [15]. Specific pathogen-free
mice were maintained on standard mouse chow (Pico-Vac Lab
Mouse Diet #5062, Brentwood, MO), and housed in a barrier
facility in accordance with both University of Calgary Animal Care
Committee and Canadian Council on Animal Care guidelines.
Weights and lengths of mice
Foridentification purposes,newborn pups weremarked with dots
on the base of the footpad according to the Ketchum Manufactur-
ing’s (Brockville, ON, Canada) tattooing protocol. Weights were
determined every three to four days for up to three weeks, and
length measurements (from the tip of the nose to the base of the tail)
were taken at birth and again at 3.5 and 4 weeks of age.
Microcomputed tomography
Micro-CT scanning (vivaCT 40, Scanco Medical, Basserdorf,
Switzerland) was performed at different locations on 4 wk old mice
(skull, spine, knees). Scanning was done at 10 mm isotropic
resolution (55 kVp, 109 mA, 400 ms integration time, 2,000
projections on 360u, 2048 CCD detector array, and cone-beam
reconstruction) and images were taken at various orientations and
cutplanes. X-ray images of the whole animal or of distinct regions
were also taken using this instrument. The generalized shape
images were obtained as described [39,40]. This refers to the mean
shape as obtained through scaling, superimposition, and averaging
of the volumetric image data for the entire sample. For the cortical
analysis, a 1.5 mm section of the mid-shaft of the femur was
scanned and evaluated using semi-automatically drawn counters
and were thresholded and Gaussian filtered (sigma=1.2, sup-
port=1), to form binarized images upon which measures of
cortical thickness could be obtained [41].
Histopathology
Knees were fixed in 4% paraformaldehyde for 7 days then
decalcified in 14% EDTA. Ear samples were fixed in 10%
formalin, and lungs were inflated and fixed with 10% formalin
delivered via a cannula inserted into the proximal trachea.
Samples from knees, ears and trachea were embedded into 50:50
paraffin blocks and cut into 4 mm sections. Histology stains
included hematoxylin and eosin, and a triple-stain, consisting of
hematoxylin, fast green and safranin-O. For detection of
proliferating cells, mice were injected with 100 mg/kg BrdU
2 hrs prior to euthanasia; replicating cells were detected via
staining with a BrdU Kit (Zymed, Invitrogen Corporation,
Carlsbad, CA); alternatively, cell proliferation was assessed using
an anti-PCNA antibody (1:50, Santa-Cruz Biotechnology, Santa
Cruz, CA) in combination with the Vectastain ABC Rabbit Kit,
(Burlingame, CA), using hematoxylin as the counter-stain.
Apoptosis was measured using the TUNEL method (Chemicon
Apoptag kit, Millipore, Billerica, MA) with methyl-green counter-
staining. Quantification of proliferating and apoptotic cells was
done by averaging positive cells from 2–4 serial sections within the
proliferative zone of the growth plate of both the distal femurs and
proximal tibiae of the mice.
Immunoblotting
Rabbit antibodies raised against thioredoxin reductase 1 (TR1)
were prepared in the laboratory of DLH. Anti-rabbit-HRP-
conjugated secondary antibody was obtained from Sigma (St.
Louis, MO); NuPAGE 4–12% polyacrylamide gels and PVDF
membranes were from Invitrogen (Carlsbad, CA), and Super-
Signal West Dura Extended Duration Substrate was from Thermo
Scientific (Rockford, IL). Chondrocyte samples were isolated from
ribs of 10 day old mice through successive digestions with pronase
(2 mg/ml) and collagenase D (3 mg/ml). Chondrocyte and liver
protein extracts prepared from control and knockout mice were
subjected to electrophoresis on NuPAGE 4–12% polyacrylamide
gels, transferred to PVDF membranes and immunoblotted with
anti-TR1 antibody (1:1000 dilution). Membranes were washed
with 0.1% TBS-T (20 mM Tris/HCl, pH 7.5, 150 mM NaCl and
0.1% Tween 20) and anti-rabbit-HRP-conjugated secondary
antibody (1:20000) was used. Following incubation with the
secondary antibody, membranes were washed with 0.1% TBS-T,
incubated in SuperSignal West Dura Extended Duration Sub-
strate and exposed to X-ray film.
Statistics
Where applicable, samples were compared using a standard
student’s t-test.
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